Identifying Adverse Events in Outpatients With Prostate Cancer Using Pharmaceutical Care Records in Community Pharmacies: Application of Named Entity Recognition
BackgroundAndrogen receptor axis-targeting reagents (ARATs) have become key drugs for patients with castration-resistant prostate cancer (CRPC). ARATs are taken long term in outpatient settings, and effective adverse event (AE) monitoring can help prolong treatment duration f...
Guardat en:
| Autors principals: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
JMIR Publications
2025-03-01
|
| Col·lecció: | JMIR Cancer |
| Accés en línia: | https://cancer.jmir.org/2025/1/e69663 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|